Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An encoded particle array tool for multiplex bioassays.

Mark Evans1, Ciaran Sewter, Elizabeth Hill

  • 13D Molecular Sciences Limited, Harston, Cambridge, UK.

Assay and Drug Development Technologies
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-analysis of survival by phased-variant ctDNA and PET response in large B-cell lymphoma.

Blood advances·2026
Same author

Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphoma.

Annals of hematology·2026
Same author

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Nature communications·2026
Same author

Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.

Diabetologia·2026
Same author

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

Hematological oncology·2026
Same author

Co-design of an animated resource to understand inequities in access to diabetes technologies among children and young people with type 1 diabetes from ethnic minority groups and/or low socioeconomic areas.

Diabetes & metabolic syndrome·2026
Same journal

Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.

Assay and drug development technologies·2026
Same journal

Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.

Assay and drug development technologies·2026
Same journal

Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.

Assay and drug development technologies·2026
Same journal

Comprehensive Physicochemical Characterization and Release Kinetics of an Astaxanthin Nanoplex: Integrated <i>In Silico</i> and <i>In Vitro</i> Evaluation.

Assay and drug development technologies·2026
Same journal

Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.

Assay and drug development technologies·2026
Same journal

Ellagic Acid-Loaded Microsponges Impregnated Chitosan-Guar Gum Hydrogel for Wound Therapy: Investigation on Rheology, Antioxidant, and Antimicrobial Activities.

Assay and drug development technologies·2026
See all related articles

This study introduces a novel, low-cost multiplex bioassay system using MEMS technology. The system enables flexible, sensitive microarray assays for drug discovery and diagnostics at reduced costs.

Area of Science:

  • Biotechnology
  • Genomics and Proteomics
  • Medical Diagnostics

Background:

  • Gene and protein assays are crucial for drug discovery and diagnostics.
  • Current methods face cost and reagent volume limitations for large-scale analysis.
  • There is a growing demand for cost-effective, high-throughput multiplex bioassays.

Purpose of the Study:

  • To develop an affordable and flexible analytical system for multiplex bioassays.
  • To address the need for low-cost, low-reagent-volume bioassay analysis.
  • To provide an alternative consumable for current microarray technologies.

Main Methods:

  • Utilized inexpensive fabricated polymeric material produced by standard Microelectromechanical Systems (MEMS) technology.
  • Employed various coupling chemistries for attaching oligonucleotides, proteins, antibodies, and antigens.

Related Experiment Videos

  • Enabled analysis via simple scanning with a flow cytometer or optical reader.

    • Main Results:

    • Developed a robust and sensitive microarray assay system.
    • Demonstrated a low-cost approach to multiplex bioassay analysis.
    • Provided a flexible alternative consumable for existing technologies.

    Conclusions:

    • The novel MEMS-based system offers a cost-effective solution for multiplex bioassays.
    • This technology can significantly reduce research and development costs in drug discovery.
    • The system provides a sensitive and flexible platform for genomic and proteomic scale analysis.